Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1009207 New York, NY
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$100,003
+$77,616 QoQ
Shares Held
87,722
+444.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 170 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. AKBA ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 1,267,706 $101,074,198
2 ALKS
Alkermes plc.
 1,312,031 $68,750,423
3 XERS
Xeris Biopharma Holdings, Inc.
 7,804,758 $61,813,683
4 PCRX
Pacira BioSciences, Inc.
 1,950,332 $49,479,922
5 ZTS
Zoetis Inc.
 537,515 $38,625,827
6 KNSA
Kiniksa Pharmaceuticals International, plc
 569,756 $36,435,896
7 SUPN
Supernus Pharmaceuticals, Inc.
 767,668 $35,704,237
8 TAK
Takeda Pharmaceutical Co Ltd
 2,049,467 $32,852,956

All Filings in AKBA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $100,003 87,722
2026-03-31 $22,387 16,106
2025-12-31 $24,990 15,522
2025-09-30 $106,813 39,126
2025-06-30 $797,483 219,089
2025-03-31 $140,469 73,161
2024-12-31 $157,055 82,661
2024-09-30 $109,508 82,961
2022-03-31 $16,188 22,547
2021-12-31 $32,528 14,393
2020-12-31 $1,166,432 416,583
2020-09-30 $5,096,228 2,030,370
2020-06-30 $31,530,138 2,321,807
2020-03-31 $9,944,694 1,311,965